Business
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market.
About this update from Cardiac Biotech Solutions Inc.
[{"type":"text","content":"Shareholders to benefit from greater transparency and improved liquidityESCONDIDO, CA / ACCESSWIRE / April 6, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products and services, today announces its successful uplisting from the OTC Pink Sheets to the OTCQB® Venture Market (the "OTCQB"). The Company will commence trading on the OTCQB with the market open on April 6, 2022, under the symbol "CBSC.""Trading on OTCQB is an important achievement for our Company, providing increased transparency and improved liquidity to both existing and prospective shareholders," said Charles Martin, Chief Executive Officer of CB Scientific, Inc. "In combination with plans underway for ongoing corporate growth through the balance of the year, we believe listing on the OTCQB will allow our story to reach a wider investor audience, a key objective for the Company in 2022."OTCQB is operated by OTC Markets Group, Inc. and is designed for early-stage and developing companies in the United States and abroad. To be eligible for OTCQB quotes, companies must be current in their disclosure filings, have audited financial statements, and undergo an annual validation and management certification process. Companies must also meet minimum bid testing and other financial terms. OTCQB is recognized as an established public market by the Securities and Exchange Commission ("SEC") and provides current public information to investors in need of securities analysis, valuation, and trading."Realizing this significant accomplishment represents another major milestone in the Company's pursuit of planned business objectives," said Paul Danner, Chairman of CB Scientific, Inc. "We are now positioned to move forward with our plans to implement a corporate name change which more accurately describes our business direction and future growth potential, and relocation of our corporate domicile to Nevada which provides superior tax laws and corporate regulations."As additional new developments occur, CB Scientific, Inc. plans to make timely announcements through press releases and regulatory filings to keep its shareholders, industry participants, and the public markets informed.A...